MedPath

APO-ARIPIPRAZOLE DEPOT

APO-ARIPIPRAZOLE DEPOT

Approved
DIN Number

02556286

Drug Class

Human

Market Date

N/A

Company
HC

Apotex Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02556286
AIG Number0152514007
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N05AX12 ARIPIPRAZOLE
Product Specifications
Dosage FormPowder For Suspension, Sustained-Release ,  Kit
Route of AdministrationIntramuscular
AHFS Classification28:16.08.04
Health Canada Classification

ACTIVE INGREDIENTS (1)

ARIPIPRAZOLEActive
Strength: 300 MG / VIAL
Monograph: ARIPIPRAZOLE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.